Post #1986587

Three days, ago VRBPAC meeting for "…recommendations on the selection of the 2026-2027 Formula for COVID-19 vaccines for use in the United States…" was announced, 28th May: https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-meeting-may-28-2026-announcement I am very much looking forward to Doctor Thornburg's May 2026 presentation on epidemiology and genomics. I watched in 2023 and 2024 because Australia buys USA vaccines (only Pfizer now), didn't watch in 2025 for [reasons], didn't even know if it was going to happen, but have just caught up with 2025 somewhat: https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-may-22-2025-meeting-announcement It's six hours long. Being USA, the focus is presentations from Moderna, Pfizer, and Novavax/Sanofi. If interested in viral evolution (and vaccine effectiveness), I would draw your attention to these two presentations with timestamps and documents: Natalie J. Thornburg, PhD Genomics, epidemiology, mutations, evolution, and a great explanation of the physical structures making up the spike protein: https://www.youtube.com/live/WX8rfa_f5o0?t=2363 Associated Document: https://www.fda.gov/media/186593/download Professor Kanta Subbarao Vaccine cross neutralisation, also with reference to evolution and mutations: https://www.youtube.com/live/WX8rfa_f5o0?t=6453 Associated Document: https://www.fda.gov/media/186598/download